Unknown

Dataset Information

0

LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGF?/Smad signaling.


ABSTRACT: LIM and SH3 protein 1(LASP1) can promote colorectal cancer (CRC) progression and metastasis, but the mechanism remains unclear. Here, we show that LASP1 interacts with S100 calcium binding protein A11(S100A11) and enhances its expression in CRC. LASP1-S100A11 axis is essential for TGF?-mediated epithelial-mesenchymal transition (EMT) and cell aggressive phenotype. Clinically, S100A11 is overexpressed in CRC tissues and localized in both the cytoplasm and the nucleus of CRC cells. Overexpression of S100A11 in cytoplasmic and nuclear subcellular compartments is associated with tumor metastasis and poor prognosis of CRC patients. Introduction of cytoplasmic and nuclear S100A11 promotes aggressive phenotypes of CRC cells in vitro as well as growth and metastasis of CRC xenografts, whereas suppressing S100A11 abrogates these effects. Furthermore, we identify flotillin-1 (FLOT1) and histone H1 as downstream factors for cytoplasmic and nuclear pathway of S100A11, which are required for LASP1-S100A11 axis-mediated EMT and CRC progression. These findings indicate S100A11, combined with LASP1, plays a critical role in promoting CRC metastasis via its subcellular effectors, FLOT1 and histone H1.

SUBMITTER: Niu Y 

PROVIDER: S-EPMC4867635 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.

Niu Ya Y   Shao Ziyun Z   Wang Hui H   Yang Jiaqi J   Zhang Feifei F   Luo Yuhao Y   Xu Lijun L   Ding Yanqing Y   Zhao Liang L  

Scientific reports 20160516


LIM and SH3 protein 1(LASP1) can promote colorectal cancer (CRC) progression and metastasis, but the mechanism remains unclear. Here, we show that LASP1 interacts with S100 calcium binding protein A11(S100A11) and enhances its expression in CRC. LASP1-S100A11 axis is essential for TGFβ-mediated epithelial-mesenchymal transition (EMT) and cell aggressive phenotype. Clinically, S100A11 is overexpressed in CRC tissues and localized in both the cytoplasm and the nucleus of CRC cells. Overexpression  ...[more]

Similar Datasets

| S-EPMC4663757 | biostudies-literature
| S-SCDT-EMBOJ-2020-106151 | biostudies-other
| S-EPMC4365692 | biostudies-literature
| S-EPMC7442651 | biostudies-literature
| S-EPMC4599274 | biostudies-literature
| S-EPMC8668282 | biostudies-literature
| S-EPMC7055097 | biostudies-literature